Shares of Corbus Pharmaceuticals Holdings Inc. CRBP were unchanged Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.31% to 12,036.79 and the Dow Jones Industrial Average DJIA rising 1.54% to 30,046.24. Corbus Pharmaceuticals Holdings Inc. closed $8.56 short of its 52-week high ($9.78), which the company achieved on August 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Fate Therapeutics Inc. FATE rose 1.81% to $55.27, Vanda Pharmaceuticals Inc. VNDA rose 0.98% to $12.34, and Viking Therapeutics Inc. VKTX fell 1.42% to $6.26. Trading volume (3.1 M) remained 1.8 million below its 50-day average volume of 4.9 M.